Shares of Marrone Bio Innovations (NASDAQ:MBII) fell 4.8% in after-market trading after the company reported Q2 results.
Quarterly Results
Earnings per share increased 0.00% year over year to ($0.02), which missed the estimate of ($0.01).
Marrone Bio Innovations (NASDAQ:MBII) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $(0.01) by 100 percent. This is unchanged from the same period last year. The company
Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI or "Marrone Bio"), an international leader in sustainable bioprotection and plant health solutions to support global agricultural needs, and Terramera, a global
Companies Reporting Before The Bell
• Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second quarter.
• Data Storage (NASDAQ:DTST) is expected to report earnings for its second quarter.